Nitric oxide-induced motility in aortic smooth muscle cells: Role of protein tyrosine phosphatase SHP-2 and GTP-binding protein Rho

Circulation Research

Volumn 91, Issue 5, 2002, Pages 390-397

  Chang, Yingzi ^a   Ceacareanu, Bogdan ^a   Dixit, Madhulika ^a   Sreejayan, Nair ^a   Hassid, Aviv ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Cell motility; Nitric oxide; Rho; SHP 2

Indexed keywords

ADENOVIRUS VECTOR; FASUDIL; NITRIC OXIDE; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE SHP 2; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG;

ALLELE; ANGIOGENESIS; ANIMAL CELL; AORTA MEDIA; ARTICLE; CELL MOTILITY; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENE OVEREXPRESSION; INTIMA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REGULATORY MECHANISM; SMOOTH MUSCLE FIBER; VIRUS RECOMBINANT;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ANIMALS; AORTA; CELL MOVEMENT; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GENETIC VECTORS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MUSCLE, SMOOTH, VASCULAR; MUTATION; NITRIC OXIDE; NITRIC OXIDE DONORS; PENICILLAMINE; PEPTIDE FRAGMENTS; PHOSPHOTYROSINE; PROTEIN-TYROSINE-PHOSPHATASE; RATS; RATS, SPRAGUE-DAWLEY; RHOA GTP-BINDING PROTEIN;

EID: 0037031978     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000033524.92083.64     Document Type: Article

References (51)

1. Perspectives series: Cell adhesion in vascular biology: Smooth muscle migration in atherosclerosis and restenosis
2. Molecular mechanisms of coronary collateral vessel growth
3. Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells
4. NO alters cell shape and motility in aortic smooth muscle cells via protein tyrosine phosphatase 1B activation
5. NO attenuates insulin signaling and motility in aortic smooth muscle cells via a protein tyrosine phosphatase 1B-mediated mechanism
6. Nitric oxide and C-type atrial natriuretic peptide stimulate primary aortic smooth muscle cell migration via a cGMP-dependent mechanism: Relationship to microfilament dissociation and altered cell morphology
7. Requirement of protein tyrosine phosphatase SHP2 for NO-stimulated vascular smooth muscle cell motility
8. Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2
9. Predominant expression of the src homology 2-containing tyrosine phosphatase protein SHP2 in vascular smooth muscle cells
10. Protein-tyrosine phosphatase Shp-2 regulates cell spreading, migration, and focal adhesion
11. Tyrosine phosphatase SHP-2 is involved in regulation of platelet-derived growth factor-induced migration
12. SHP-2 binds to Tyr763 and Tyr1009 in the PDGF β-receptor and mediates PDGF-induced activation of the Ras/MAP kinase pathway and chemotaxis
13. Concerted activity of tyrosine phosphatase SHP-2 and focal adhesion kinase in regulation of cell motility
14. Regulation of angiotensin II-induced JAK2 tyrosine phosphorylation: Roles of SHP-1 and SHP-2
15. The protein tyrosine phosphatase Shp-2 regulates RhoA activity
16. Regulation of Ras and Rho small G proteins by SHP-2
17. 2+ sensitization of contraction in vascular smooth muscle
18. Nitric oxide induces dilation of rat aorta via inhibition of rho-kinase signaling
19. RhoA inactivation by p190RhoGAP regulates cell spreading and migration by promoting membrane protrusion and polarity
20. A simple method for the rapid generation of recombinant adenovirus vectors
21. The phosphotyrosine phosphatase PTP1D, but not PTP1C, is an essential mediator of fibroblast proliferation induced by tyrosine kinase and G protein-coupled receptors
22. Site-specific incorporation of a phosphotyrosine mimetic reveals a role for tyrosine phosphorylation of SHP-2 in cell signaling
23. Proteintyrosine phosphatase 1D modulates its own state of tyrosine phosphorylation
24. Rho kinase inhibitor HA-1077 prevents Rho-mediated myosin phosphatase inhibition in smooth muscle cells
25. Molecular characterization of specific interactions between SHP-2 phosphatase and JAK tyrosine kinases
26. Cultured aortic smooth muscle cells from newborn and adult rats show distinct cytoskeletal features
27. Nitric oxide-generating vasodilators and 8-bromocyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells
28. Nitric oxide selectively amplifies FGF-2-induced mitogenesis in primary rat aortic smooth muscle cells
29. Activation of mitogen-activated protein kinase pathways by cyclic GMP and cyclic GMP-dependent protein kinase in contractile vascular smooth muscle cells
30. 1 of platelet-derived growth factor- stimulated proliferation of vascular smooth muscle cells from SHR and WKY rats
31. Apoptotic, nonapoptotic, and anti-apoptotic pathways of tumor necrosis factor signalling
32. Protein tyrosine phosphatases in signal transduction
33. Receptor-binding, tyrosine phosphorylation and chromosome localization of the mouse SH2-containing phosphotyrosine phosphatase Syp
34. Protein-tyrosine-phosphatase SHPTP2 couples platelet-derived growth factor receptor β to Ras
35. cGMP-dependent protein kinase phosphorylates, and inactivates Rho A
36. Rho and Rho kinase mediate thrombin-stimulated vascular smooth muscle cell DNA synthesis and migration
37. The kinase inhibitor fasudil (HA-1077) reduces intimal hyperplasia through inhibiting migration and enhancing cell loss of vascular smooth muscle cells
38. Interplay between Rac and Rho in the control of substrate contact dynamics
39. Effect of nitric oxide on the adhesion of human melanocytes to extracellular matrix components
40. Exogenous nitric oxide inhibits mesangial cell adhesion to extracellular matrix components
41. Stimulation of phosphatidylinositol-4-phosphate 5-kinase by Rho-kinase
42. Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase
43. Bidirectional signaling between the cytoskeleton and integrins
44. Regulation of myosin phosphatase by a specific interaction with cGMP-dependent protein kinase Iα
45. Overexpression of inducible nitric oxide synthase by neointimal smooth muscle cells
46. Decreased neointimal thickening after arterial wall injury in inducible nitric oxide synthase knockout mice
47. Inducible nitric oxide: An autoregulatory feedback inhibitor of vascular inflammation
48. Pericyte involvement in capillary sprouting during angiogenesis in situ
49. Role of NO in flow-induced remodeling of the rabbit common carotid artery
50. Ischemia-induced coronary collateral growth is dependent on vascular endothelial growth factor and nitric oxide
51. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia